DAGVX | VIVIX | DAGVX / VIVIX | |
Total Expense Ratio | 0.93 | 0.04 | 2,325% |
Annual Report Gross Expense Ratio | 0.95 | 0.04 | 2,375% |
Fund Existence | 30 years | 27 years | - |
Gain YTD | 10.907 | 6.730 | 162% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.9B | 195B | 5% |
Annual Yield % from dividends | 0.86 | 2.19 | 39% |
Returns for 1 year | 9.31 | 9.75 | 95% |
Returns for 3 years | 27.66 | 34.32 | 81% |
Returns for 5 years | 57.06 | 74.87 | 76% |
Returns for 10 years | 26.63 | 116.26 | 23% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XDOC | 33.07 | 0.10 | +0.30% |
Innovator US Equity Accelerated ETF Oct | |||
OMFS | 40.87 | 0.11 | +0.26% |
Invesco Russell 2000® Dynamic Mltfct ETF | |||
XISE | 30.42 | 0.01 | +0.03% |
FT Vest US Eq Buf & Prm IncETF-Sept | |||
NAUG | 27.94 | N/A | N/A |
Innovator Growth-100 Pwr Buffr ETF - Aug | |||
HQH | 16.19 | -0.03 | -0.18% |
abrdn Healthcare Investors |